Recruiting

Observational Study

Sponsor:

Akouos, Inc.

Code:

NCT05572073

Conditions

Sensorineural Hearing Loss, Bilateral

Eligibility Criteria

Sex: All

Age: 0 - 44

Healthy Volunteers: Not accepted

Interventions

Natural History Study

Study Details

Brief summary:

This is a retrospective and prospective longitudinal study in participants with Otoferlin Gene-Mediated Hearing Loss.

Conditions

Sensorineural Hearing Loss, Bilateral

Study ID

NCT05572073

Start date

Jul 14, 2022

Status verified date

Dec, 2025

Completion date

Feb, 2029

Anticipated

Primary completion date

Feb, 2029

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0 - 44

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. Clinical presentation of bilateral sensorineural hearing loss (SNHL), including auditory neuropathy (AN) / auditory neuropathy spectrum disorder (ANSD) phenotype or medical history of AN / ANSD phenotype earlier in life
2. Mutation(s) in the otoferlin gene
3. Able and willing to comply with all study requirements, as evidenced by successful completion of the informed consent (and assent, if applicable) process

Additional Criteria for Inclusion in the Prospective Phase:
4. Presence of OAE / CM and absent / abnormal ABRs in at least one ear (that does not have a cochlear implant) within 12 months prior to or at the Month 0 visit

Exclusion Criteria:

1. Unwillingness or inability of the potential participant and/or legally authorized representative to comply with all protocol requirements
2. Presence of cochlear nerve deficiency and/or cochlear nerve dysplasia

Additional Criteria for Exclusion from the Prospective Phase:
3. Presence of bilateral cochlear implants at the time of record review or planned within the next 6 months
4. Presence of middle ear or auditory brainstem implant(s) at the time of record review or planned within the next 6 months
5. Any condition that would not allow the potential participant to complete follow-up assessments during the course of the study and/or, in the opinion of the Investigator, makes the potential participant unsuitable for the study

Note: Potential participants will not be excluded based on their sex, gender, race, or ethnicity

Study Design

Enrollment

150 participants

Anticipated

Interventions and Outcome Measures

Arms

Retrospective

Prospective

Interventions

Natural History Study

Natural History Study

Primary outcome measure

  • ABR [ Time Frame: First audiologic data in participant medical record through five-year prospective follow up ]

Central Contacts and Locations

Central contacts

Locations

University of Iowa

Recruiting

Iowa City, Iowa, United States, 52242

Cincinnati Children's Hospital Medical Center

Recruiting

Cincinnati, Ohio, United States, 45229

Children's Hospital of Philadelphia

Recruiting

Philadelphia, Pennsylvania, United States, 19104

Vanderbilt University Medical Center

Recruiting

Nashville, Tennessee, United States, 37232-8605

More Information

Sponsor

Akouos, Inc.

Last update posted

Mar 4, 2026

Last verified

Dec, 2025

Keywords

  • Otoferlin Gene, sensorineural hearing loss (SNHL), auditory neuropathy, auditory neuropathy spectrum disorder

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Akouos, Inc. on 2026-03-04.